Skip to main content
©Klinikum rechts der Isar Michael Stobrawe I Helmholtz Munich

Prof. Dr. Stephanie E. Combs

Director, Institute of Radiation Medicine (IRM)

 

Prof. Dr. Stephanie E. Combs

Director, Institute of Radiation Medicine (IRM)

 +49 89 4140 4501  

 

Career

Stephanie E. Combs is a leading expert in the field of radiation oncology. Her central expertise is high precision radiation therapy (stereotaxy, IMRT/IGRT/ART, protons/heavy ions), radiobiology, and combination therapies with radiation. Her scientific work includes therapy optimization of brain and skull base tumors, biomarkers in radiooncology, pediatric oncology, gastrointestinal oncology, uro-oncology, gynecologic oncology, radiochemotherapy and radioimmunotherapy.

Stephanie E. Combs works with her interdisciplinary team on different platforms. She herself implements this networking out of conviction: She is director of the Institute of Radiation Medicine at Helmholtz Munich and director of the Department of Radiation Oncology at the Technical University of Munich (TUM), Chair of the Senate at TUM and of several national and EU-wide research networks.

The Institute of Radiation Medicine works closely with the Department of Radiation Oncology at the University Hospital "rechts der Isar" and physicians throughout Germany and Europe, and is thus able to explore findings discovered in the laboratory in patients and bring new therapeutic approaches to the clinic.

Academic Pathway

Prof. Dr. Combs studied medicine at the University of Heidelberg, Germany, with intermittent studies abroad at Eastern Virginia Medical School, Norfolk, VA, USA and the University of Texas (UTHSCSA), San Antonio, TX, USA. After receiving her doctorate in 2003, she worked as a research associate in Heidelberg. In 2009, she finished her Habilitation. In 2011, she was working as a senior physician at the Department of Radiation Oncology at Heidelberg University Hospital, Germany. Since 2014, Prof. Combs is the director of the Department of Radiation Oncology at TUM, Munich, Germany and since 2015 she is the director of the Institute of Radiation Medicine at Helmholtz Munich. In 2015, she initiated a Masters Course, Master of Radiation Biology. In 2019, Prof. Combs became Chair of the Senate at TUM.

 

 

Skills and Expertise

RadioOncologyHigh precision radiation therapy  Radiobiology  Combination therapies  Master of Radiation Biology      

Professional Career

Since 2022

Dean

Faculty of Medicine, Technische Universität München (TUM), Germany

Since 2015

Director

Institute of Radiation Medicine (IRM), Helmholtz Munich, Germany

Since 2014

Professor and Chair

Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München (TUM), Germany

2011-2014

Vice Chairman

Department of Radiation Oncology, University Hospital of Heidelberg, Germany

2011

Diploma in Palliative Care

Heidelberg, Germany

2009

Board Certification for Radiation Oncology

2009

Postdoctoral Lecturer Qualification (Habilitation)

Heidelberg, Germany

2007-2014

Head of the Neuro-Radiation Oncology Research Group

Department of Radiation On-cology, University Hospital Heidelberg, Germany

2003-2014

Postdoc and Residency

Postdoc and Residency, Department of Radiation Oncology, University Hospital Heidelberg

2003-2005

Postdoc and Residency

Postdoc and Residency, Clinical Cooperation Unit Radiation Oncology, Deutsches Krebsforschungszentrum (DKFZ), Germany

1996-2003

Medical School

Medical School, Ruprecht-Karls-Universität in Heidelberg, Eastern Virginia Medical School, Norfolk, VA, USA, University of Texas (UTHSCSA), San Antonio, TX, USA

  

Honors and Awards

2019
Basic/Translational Senior Science of the American Society of Radiation Oncology
2012
1. Robert Janker Award for Palliative Care
2010
Herrmann Holthusen Award of the German Society for Radiation Oncology (DEGRO)
2010
1. Behnken-Berger-Preis of the Behnken-Berger Foundation

Most important publications

2020 JAMA Oncology

Chad G Rusthoven, Masaaki Yamamoto, Denise Bernhardt, Derek E Smith, Dexiang Gao, Toru Serizawa, Shoji Yomo, Hitoshi Aiyama, Yoshinori Higuchi, Takashi Shuto, Atsuya Akabane, Yasunori Sato, Ajay Niranjan, Andrew M Faramand, L Dade Lunsford, James McInerney, Leonard C Tuanquin, Brad E Zacharia, Veronica Chiang, Charu Singh, James B Yu, Steve Braunstein, David Mathieu, Charles J Touchette, Cheng-Chia Lee, Huai-Che Yang, Ayal A Aizer, Daniel N Cagney, Michael D Chan, Douglas Kondziolka, Kenneth Bernstein, Joshua S Silverman, Inga S Grills, Zaid A Siddiqui, Justin C Yuan, Jason P Sheehan, Diogo Cordeiro, Kename Nosaki, Takahashi Seto, Christopher P Deibert, Vivek Verma, Samuel Day, Lia M Halasz, Ronald E Warnick, Daniel M Trifiletti, Joshua D Palmer, Albert Attia, Benjamin Li, Christopher P Cifarelli, Paul D Brown, John A Vargo, Stephanie E Combs, Kerstin A Kessel, Stefan Rieken, Samir Patel, Matthias Guckenberger, Nicolaus Andratschke, Brian D Kavanagh, Tyler P Robin

Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases

Networks and Affiliations